{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:04:56Z","timestamp":1791893096449,"version":"4.3.4"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.eprac.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:39:24Z","timestamp":1790033964000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Papillary Thyroid Microcarcinoma in the Era of Risk-Adapted Management"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4110-5370","authenticated-orcid":false,"given":"Hon-Fan","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9714-4614","authenticated-orcid":false,"given":"Chen-Hsen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2026.09.002_bib1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMp1604412","article-title":"Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis","volume":"375","author":"Vaccarella","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eprac.2026.09.002_bib2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1056\/NEJMp1409841","article-title":"Korea's thyroid-cancer \"epidemic\"--screening and overdiagnosis","volume":"371","author":"Ahn","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eprac.2026.09.002_bib3","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1002\/lary.21076","article-title":"The increasing incidence of small thyroid cancers: where are the cases coming from?","volume":"120","author":"Davies","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.eprac.2026.09.002_bib4","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.surg.2008.08.023","article-title":"Increasing incidence of thyroid cancer is due to increased pathologic detection","volume":"144","author":"Grodski","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.eprac.2026.09.002_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0039-6109(16)46633-8","article-title":"Surgical management of the patient with papillary cancer","volume":"75","author":"Patwardhan","year":"1995","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.eprac.2026.09.002_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41574-025-01168-y","article-title":"Unravelling the rise in thyroid cancer incidence and addressing overdiagnosis","volume":"22","author":"Chen","year":"2026","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.eprac.2026.09.002_bib7","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1089\/thy.2022.0325","article-title":"Active surveillance of papillary thyroid cancer: Frequency and time course of the six Most common tumor volume kinetic patterns","volume":"32","author":"Tuttle","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/thy.2023.0076","article-title":"Long-term outcomes of active surveillance and immediate surgery for adult patients with low-risk Papillary Thyroid Microcarcinoma: 30-year experience","volume":"33","author":"Miyauchi","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib9","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1089\/thy.2021.0614","article-title":"Progression of low-risk Papillary Thyroid Microcarcinoma during active surveillance: interim analysis of a multicenter prospective cohort study of active surveillance on Papillary Thyroid Microcarcinoma in Korea","volume":"32","author":"Lee","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/thy.2015.0313","article-title":"Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery","volume":"26","author":"Oda","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1089\/thy.2019.0707","article-title":"Efficacy and safety of thermal ablation techniques for the treatment of primary papillary Thyroid Microcarcinoma: a systematic review and meta-analysis","volume":"30","author":"Choi","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaoto.2021.4381","article-title":"Assessment of radiofrequency ablation for papillary microcarcinoma of the thyroid: a systematic review and meta-analysis","volume":"148","author":"van Dijk","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.eprac.2026.09.002_bib13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jamaoncol.2016.3288","article-title":"Mortality risk stratification by combining BRAF V600E and TERT promoter mutations in papillary thyroid cancer: genetic duet of BRAF and TERT promoter mutations in thyroid cancer mortality","volume":"3","author":"Liu","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eprac.2026.09.002_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/thy.2016.0350","article-title":"Effects of coexistent BRAFV600E and TERT promoter mutations on poor clinical outcomes in papillary thyroid cancer: a meta-analysis","volume":"27","author":"Moon","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3","article-title":"Occult papillary carcinoma of the thyroid. A \"normal\" finding in Finland. A systematic autopsy study","volume":"56","author":"Harach","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.eprac.2026.09.002_bib16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0002-9343(94)90321-2","article-title":"Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer","volume":"97","author":"Mazzaferri","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.eprac.2026.09.002_bib17","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/archinte.1996.00440180017002","article-title":"Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association","volume":"156","author":"Singer","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eprac.2026.09.002_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/thy.2006.16.109","article-title":"Management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"16","author":"Cooper","year":"2006","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association Management Guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12957-017-1130-7","article-title":"Total thyroidectomy may be more reasonable as initial surgery in unilateral multifocal papillary thyroid microcarcinoma: a single-center experience","volume":"15","author":"Xue","year":"2017","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.eprac.2026.09.002_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.655608","article-title":"Extent of surgery and the prognosis of unilateral papillary Thyroid Microcarcinoma","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.eprac.2026.09.002_bib24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.surg.2016.07.037","article-title":"Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: analysis of 8,676 patients at a single institution","volume":"161","author":"Kim","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.eprac.2026.09.002_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/EJE-16-0845","article-title":"A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study","volume":"176","author":"Kwon","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2026.09.002_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2025.109937","article-title":"Total thyroidectomy versus lobectomy for unilateral papillary thyroid cancer and lateral lymph node metastasis: a systematic review and meta-analysis","volume":"190","author":"Wu","year":"2026","journal-title":"Surgery"},{"key":"10.1016\/j.eprac.2026.09.002_bib27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1089\/thy.2009.0159","article-title":"Consensus statement on the terminology and classification of central neck dissection for thyroid cancer","volume":"19","author":"American Thyroid Association Surgery Working Group","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12957-022-02573-7","article-title":"Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis","volume":"20","author":"Wen","year":"2022","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.eprac.2026.09.002_bib29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.21037\/gs.2020.03.03","article-title":"Impact of prophylactic unilateral central neck dissection needed for patients with papillary thyroid microcarcinoma","volume":"9","author":"Ryu","year":"2020","journal-title":"Gland Surg"},{"key":"10.1016\/j.eprac.2026.09.002_bib30","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00268-013-2348-3","article-title":"Lobectomy and prophylactic central neck dissection for papillary thyroid microcarcinoma: do involved lymph nodes mandate completion thyroidectomy?","volume":"38","author":"Lee","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.eprac.2026.09.002_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/ans.19210","article-title":"Effectiveness of prophylactic central compartment neck dissection following hemithyroidectomy in papillary thyroid cancer: a meta-analysis","volume":"95","author":"Zhao","year":"2025","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.eprac.2026.09.002_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/571480","article-title":"The benefits and risks of prophylactic central neck dissection for papillary thyroid carcinoma: prospective cohort study","volume":"2015","author":"Lee","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.eprac.2026.09.002_bib33","article-title":"Is prophylactic central neck dissection necessary for patients with clinically node-negative papillary thyroid microcarcinoma? A follow-up study of more than 10 years","volume":"16","author":"Wu","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.eprac.2026.09.002_bib34","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.3390\/cancers12103032","article-title":"Completion total thyroidectomy is not necessary for papillary thyroid microcarcinoma with occult central lymph node metastasis: a long-term serial follow-up","volume":"12","author":"Choi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.eprac.2026.09.002_bib35","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1089\/thy.2012.0463","article-title":"Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching","volume":"23","author":"Lee","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/105072503321669875","article-title":"An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid","volume":"13","author":"Ito","year":"2003","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1507\/endocrj.46.209","article-title":"Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors","volume":"46","author":"Sugitani","year":"1999","journal-title":"Endocr J"},{"key":"10.1016\/j.eprac.2026.09.002_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/thy.2013.0367","article-title":"Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation","volume":"24","author":"Ito","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib39","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s00268-009-0359-x","article-title":"Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes","volume":"34","author":"Sugitani","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.eprac.2026.09.002_bib40","series-title":"2010 Treatment of Thyroid Tumor. Japanese Clinical Guidelines","year":"2010"},{"key":"10.1016\/j.eprac.2026.09.002_bib41","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1210\/clinem\/dgz113","article-title":"Active surveillance in Papillary Thyroid Microcarcinomas is feasible and safe: experience at a single Italian center","volume":"105","author":"Molinaro","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.09.002_bib42","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jamaoto.2017.1442","article-title":"Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance","volume":"143","author":"Tuttle","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.eprac.2026.09.002_bib43","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1089\/thy.2019.0522","article-title":"Experience with active surveillance of thyroid low-risk carcinoma in a developing country","volume":"30","author":"Sanabria","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.11106\/ijt.2016.9.2.59","article-title":"2016 Revised Korean Thyroid Association management guidelines for patients with thyroid nodules and thyroid cancer","volume":"9","author":"Yi","year":"2016","journal-title":"Int J Thyroidol"},{"key":"10.1016\/j.eprac.2026.09.002_bib45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/thy.2020.0330","article-title":"Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of endocrine surgery task force on management for papillary thyroid microcarcinoma","volume":"31","author":"Sugitani","year":"2021","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.eprac.2026.09.002_bib46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jamaoto.2025.4670","article-title":"Patient-reported outcomes across treatment strategies in papillary thyroid microcarcinoma: a meta-analysis","volume":"152","author":"van Dijk","year":"2026","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.eprac.2026.09.002_bib47","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1089\/thy.2019.0211","article-title":"Active surveillance versus immediate surgery: questionnaire survey on the current treatment strategy for adult patients with low-risk Papillary Thyroid Microcarcinoma in Japan","volume":"29","author":"Sugitani","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib48","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/SLA.0000000000004417","article-title":"Barriers to the use of active surveillance for thyroid cancer results of a Physician Survey","volume":"276","author":"Hughes","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.eprac.2026.09.002_bib49","doi-asserted-by":"crossref","first-page":"784","DOI":"10.21037\/gs-24-25","article-title":"Survey of clinician perspective on management of papillary thyroid microcarcinoma in Australia and New Zealand","volume":"13","author":"Yin","year":"2024","journal-title":"Gland Surg"},{"key":"10.1016\/j.eprac.2026.09.002_bib50","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1089\/thy.2015.0178","article-title":"A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in Papillary Microcarcinoma","volume":"26","author":"Brito","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib51","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1001\/jamaoncol.2022.3875","article-title":"Expanded parameters in active surveillance for low-risk papillary thyroid carcinoma: a nonrandomized controlled trial","volume":"8","author":"Ho","year":"2022","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.eprac.2026.09.002_bib52","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamasurg.2025.2957","article-title":"Long-term durability of active surveillance of small, low-risk papillary thyroid cancer","volume":"160","author":"Sawka","year":"2025","journal-title":"JAMA Surg"},{"key":"10.1016\/j.eprac.2026.09.002_bib53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12020-019-02019-3","article-title":"Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: a systematic review and meta-analysis","volume":"67","author":"Trimboli","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.eprac.2026.09.002_bib54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/02656736.2019.1571248","article-title":"Comparison of efficacy and complications between radiofrequency ablation and repeat surgery in the treatment of locally recurrent thyroid cancers: a single-center propensity score matching study","volume":"36","author":"Choi","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.eprac.2026.09.002_bib55","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0244","article-title":"Percutaneous ablation of low-risk papillary thyroid cancer","volume":"30","author":"Tuttle","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.eprac.2026.09.002_bib56","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1080\/02656736.2019.1700559","article-title":"Efficacy and safety of radiofrequency, microwave and laser ablation for treating Papillary Thyroid Microcarcinoma: a systematic review and meta-analysis","volume":"36","author":"Tong","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.eprac.2026.09.002_bib57","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3348\/kjr.2018.19.4.632","article-title":"2017 thyroid radiofrequency ablation guideline: Korean Society of Thyroid Radiology","volume":"19","author":"Kim","year":"2018","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.eprac.2026.09.002_bib58","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/hed.26960","volume":"44","author":"Orloff","year":"2022","journal-title":"Head Neck"},{"key":"10.1016\/j.eprac.2026.09.002_bib59","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000516469","article-title":"European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the use of minimally invasive treatments in malignant thyroid lesions","volume":"10","author":"Mauri","year":"2021","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.eprac.2026.09.002_bib60","article-title":"2024 International expert consensus on US-guided thermal ablation for T1N0M0 papillary thyroid cancer","volume":"315","author":"Zhao","year":"2025","journal-title":"Radiology"},{"key":"10.1016\/j.eprac.2026.09.002_bib61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/thy.2024.0535","article-title":"Radiofrequency ablation of low-risk Papillary Thyroid Microcarcinoma: a retrospective cohort study including patients with more than 10 years of Follow-up","volume":"35","author":"Jeong","year":"2025","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib62","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.3348\/kjr.2020.1308","article-title":"Comparison of thermal ablation and surgery for low-risk Papillary Thyroid Microcarcinoma: a systematic review and meta-analysis","volume":"22","author":"Kim","year":"2021","journal-title":"Korean J Radiol"},{"issue":"1","key":"10.1016\/j.eprac.2026.09.002_bib63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.surg.2023.06.054","article-title":"Age-stratified comparison of active surveillance versus radiofrequency ablation for papillary thyroid microcarcinoma using decision analysis","volume":"175","author":"Carlisle","year":"2024","journal-title":"Surgery"},{"key":"10.1016\/j.eprac.2026.09.002_bib64","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.2013.3190","article-title":"Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer","volume":"309","author":"Xing","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.eprac.2026.09.002_bib65","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1210\/jc.2012-1775","article-title":"The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study","volume":"97","author":"Elisei","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.09.002_bib66","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/jamaoto.2013.4501","article-title":"Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience","volume":"139","author":"Gouveia","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.eprac.2026.09.002_bib67","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1210\/jc.2013-1584","article-title":"Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers","volume":"98","author":"Li","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.09.002_bib68","doi-asserted-by":"crossref","first-page":"E1562","DOI":"10.1210\/jc.2013-2383","article-title":"Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease","volume":"98","author":"Landa","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.09.002_bib69","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/thy.2015.0101","article-title":"TERT promoter mutations in papillary thyroid microcarcinomas","volume":"25","author":"de Biase","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2026.09.002_bib70","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.surg.2021.03.056","article-title":"Presence of TERT \u00b1 BRAF V600E mutation is not a risk factor for the clinical management of patients with papillary thyroid microcarcinoma","volume":"170","author":"Lee","year":"2021","journal-title":"Surgery"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:31:37Z","timestamp":1791891097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26011444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":70,"alternative-id":["S1530891X26011444"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.09.002","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Papillary Thyroid Microcarcinoma in the Era of Risk-Adapted Management","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}